Presentation is loading. Please wait.

Presentation is loading. Please wait.

The top device is the XE2, used in TITAN

Published bySusanti Sugiarto Modified over 5 years ago

Similar presentations

Presentation on theme: "The top device is the XE2, used in TITAN"— Presentation transcript:

1 The top device is the XE2, used in TITAN
The top device is the XE2, used in TITAN. The bottom device is the modified XE2 (mXE2), used in TITAN II. Among other changes, the XE2 has a ‘ski-slope’ in the wireforms next to the end, not seen in the mXE2 (thin arrows). The top device is the XE2, used in TITAN. The bottom device is the modified XE2 (mXE2), used in TITAN II. Among other changes, the XE2 has a ‘ski-slope’ in the wireforms next to the end, not seen in the mXE2 (thin arrows). There is a little distance between the crimping tube of the proximal anchor and the locking loop of the mXE2 (thick arrow), not seen in the XE2. These helped to reduce the strain in the wireforms of the proximal anchor next to the end of the device, where the majority of the fractures occurred in TITAN. Janusz Lipiecki et al. Open Heart 2016;3:e000411 ©2016 by British Cardiovascular Society

Download ppt "The top device is the XE2, used in TITAN"

Similar presentations

The CARILLON: Device Iteration, New Data and New Trials

The CARILLON: Device Iteration, New Data and New Trials
MACE rate among CAD severity groups (total 0

MACE rate among CAD severity groups (total 0
Any and definite stent thrombosis (ST) and in-device late lumen loss (LLL) with bioresorbable vascular scaffold (BVS) versus drug-eluting stent (DES) in.

Any and definite stent thrombosis (ST) and in-device late lumen loss (LLL) with bioresorbable vascular scaffold (BVS) versus drug-eluting stent (DES) in.
CT coronary angiography curved planar reconstruction of the left anterior descending coronary artery showing an atherosclerotic plaque with calcified and.

CT coronary angiography curved planar reconstruction of the left anterior descending coronary artery showing an atherosclerotic plaque with calcified and.
Forest plot of risk ratio with its 95% CI for the incidence of contrast-induced nephropathy among patient taking statin versus control based on renal impairment.

Forest plot of risk ratio with its 95% CI for the incidence of contrast-induced nephropathy among patient taking statin versus control based on renal impairment.
Kaplan-Meier curves: revascularisation rate (PCI or CABG) was significantly higher (p

Kaplan-Meier curves: revascularisation rate (PCI or CABG) was significantly higher (p
Masashi Maeda et al. Heart Asia 2013;5:7-14

Masashi Maeda et al. Heart Asia 2013;5:7-14
(A) Image of a stent that was damaged withdrawing it back into a Guideliner V2 after failing to cross the lesion. (A) Image of a stent that was damaged.

(A) Image of a stent that was damaged withdrawing it back into a Guideliner V2 after failing to cross the lesion. (A) Image of a stent that was damaged.
In this example, optical coherence tomography was performed to examine tissue coverage of a stent implanted 3 weeks prior to the left circumflex artery.

In this example, optical coherence tomography was performed to examine tissue coverage of a stent implanted 3 weeks prior to the left circumflex artery.
ECG lead II recorded from a patient with typical atrial flutter (spontaneous atrial cycle length of 264 ms). ECG lead II recorded from a patient with typical.

ECG lead II recorded from a patient with typical atrial flutter (spontaneous atrial cycle length of 264 ms). ECG lead II recorded from a patient with typical.
Bar chart of systolic function in healthy individuals, HCM LVH− patients and HCM LVH+ patients. GLS was significantly worse in the HCM LVH+ patients compared.

Bar chart of systolic function in healthy individuals, HCM LVH− patients and HCM LVH+ patients. GLS was significantly worse in the HCM LVH+ patients compared.
(A) Kaplan-Meier curve showing AF-free survival after a single procedure for patients grouped according to use of CT integration. (A) Kaplan-Meier curve.

(A) Kaplan-Meier curve showing AF-free survival after a single procedure for patients grouped according to use of CT integration. (A) Kaplan-Meier curve.
(A) 1-year mortality in relation to estimated glomerular filtration rate (eGFR), age (n=47 636) and presence of diabetes mellitus (n=47 624). (A) 1-year.

(A) 1-year mortality in relation to estimated glomerular filtration rate (eGFR), age (n=47 636) and presence of diabetes mellitus (n=47 624). (A) 1-year.
Comparison of CMR and echocardiography in aortic regurgitation.

Comparison of CMR and echocardiography in aortic regurgitation.
Changes in smoking behaviour over time.

Changes in smoking behaviour over time.
Kaplan-Meier curves showing the time in months to the first inappropriate shock from the start of remote monitoring in primary and secondary prevention.

Kaplan-Meier curves showing the time in months to the first inappropriate shock from the start of remote monitoring in primary and secondary prevention.
Toray microarray analysis of the four groups of patients (A) and in patients with calcium score >100 (B). Toray microarray analysis of the four groups.

Toray microarray analysis of the four groups of patients (A) and in patients with calcium score >100 (B). Toray microarray analysis of the four groups.
Venogram and image of the Carillon device during attempted recapture and as left in situ, prior to release, and at 3-month follow-up. Venogram and image.

Venogram and image of the Carillon device during attempted recapture and as left in situ, prior to release, and at 3-month follow-up. Venogram and image.
Absolute ST segment elevation at the beginning of the primary percutaneous coronary intervention procedure (A), after guidewire passage (B), after thrombus.

Absolute ST segment elevation at the beginning of the primary percutaneous coronary intervention procedure (A), after guidewire passage (B), after thrombus.
Trends in LVAD implantation rates among the Medicare population from 2004 to 2011. Trends in LVAD implantation rates among the Medicare population from.

Trends in LVAD implantation rates among the Medicare population from 2004 to Trends in LVAD implantation rates among the Medicare population from.

Similar presentations

Ads by Google